WHEREAS, Most children cannot be treated at a local hospital
and families must face the disruption of relocating to receive
treatment at a regional cancer center; and
WHEREAS, As a result of major treatment advances in recent
decades, 85% of children with cancer now survive five years or
more; and
WHEREAS, This is a significant increase since the mid-1970s,
when the five-year survival rate was less than 60%; and
WHEREAS, Survival rates vary depending on the type of cancer
and other factors; and
WHEREAS, There is still significant progress to be made
relating to childhood cancer treatment because many types of
childhood cancer, and some types with lower survival rates, are
very difficult to treat; and
WHEREAS, Pennsylvania is a leader in the fight against and
treatment of childhood cancer, with six Children's Oncology
Group hospitals: St. Christopher's Hospital for Children,
Children's Hospital of Philadelphia, Geisinger Medical Center,
Lehigh Valley Hospital-Cedar Crest, Penn State Health Children's
Hospital and UPMC Children's Hospital of Pittsburgh; and
WHEREAS, Penn State Health Children's Hospital is one of only
11 institutions nationwide in the Pediatric Oncology
Experimental Therapeutic Investigators' Consortium; and
WHEREAS, The Department of Transportation reported that from
August 2021 through August 2022, Pennsylvanians contributed
nearly $800,000 to the Pediatric Cancer Research Fund through
its donation feature made available during online license,
identification card and registration renewals; therefore be it
RESOLVED, That the House of Representatives designate the
month of September 2023 as "Childhood Cancer Awareness Month" in
20230HR0201PN1978 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30